AUTH/2686/1/14: Member of the public v Bristol-Myers Squibb (Clinical Trial Disclosure – Javlor) – Out of scope / No breach | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2686/1/14
Complainant	Member of the public
Company	Bristol-Myers Squibb
Topic	Clinical Trial Disclosure (Javlor)
Complaint received	02 January 2014
Completed	24 March 2014
Applicable Code year	2012
Outcome	No breach; outwith the scope of the Code
Clauses cited	Not stated
Case report	No case report (outwith scope)
Sanctions	None stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A member of the public made a complaint about Bristol-Myers Squibb relating to clinical trial disclosure for Javlor.
The matter was considered under the ABPI Code of Practice (applicable Code year: 2012).
The PMCPA concluded the complaint was outwith the scope of the Code.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →